Title of article :
Clinical Manifestation and the Risk of Exposure to SARS-CoV-2 (COVID‑19)
Author/Authors :
Aleebrahim-Dehkordi, Elahe Young Researchers and Elite Club - Shahrekord Branch Islamic Azad University, Shahrekord, Iran , Reyhanian, Ali Student Research Committee - Shahrekord University of Medical Sciences, Shahrekord, Iran , Hasanpour-Dehkordi, Ali Social Determinants of Health Research Center - School of Allied Medical Scinces - Shahrekord University of Medical Sciences, Shahrekord, Iran
Abstract :
The new coronavirus that scientifically has been
named SARS‑CoV‑2 would result in coronavirus
disease (COVID‑19). It has drawn much attention to
itself in the world; consequently, the World Health
Organization (WHO) announced in a statement that
the outbreak of the virus was a cause of public health
emergencies around the world.[1] The outbreak of
COVID‑19, the novel coronavirus, was first begun in
Wuhan, China, with widespread. Due to the increasing
prevalence of the disease in more than 120 countries, the
WHO has declared a global epidemic on March 21.[2,3]
The virus that causes COVID‑19 has been identified as
acute respiratory syndrome coronavirus (SARS‑CoV‑2).
Keywords :
Clinical Manifestation , SARS-CoV-2 (COVID‑19)
Journal title :
International Journal of Preventive Medicine (IJPM)
